EHA remembers Tessa Holyoake

Tessa Holyoake

We received the sad news of Professor Tessa Holyoake’s passing. Tessa Holyoake was a Professor of Experimental Hematology and the Head of the Paul O'Gorman Leukemia Research Centre.

Read more

A brand new EHA website!

homepage

You may already have noticed the new EHA look & feel.  We are proud to share it with you already.

Read more

CME-European Accreditors: A New European CME/CPD Association

image4

A new association of accrediting boards in Continuing Medical Education/Continuing Professional Development in Europe has been established.

Read more

European Hematology Association publishes new journal with Wolters Kluwer

Jan Cools Andreas Engert

The European Hematology Association, the largest Europe-based association of hematologists, launched its new journal HemaSphere with publisher Wolters Kluwer at the 22nd Annual Congress of EHA in Madrid.

Read more

Madrid Declaration: joint call for action on training requirements

madrid decl

The Madrid Declaration on enhanced training requirements for hematologists in the Professional Qualifications Directive enjoyed broad support from national society representatives at the EHA22 National Societies Dinner in Madrid.

Read more

Lymphoid malignancies dissected in Warsaw

20170318 162622 LLS

The EHA–PTHiT Tutorial on Lymphoid Malignancies was held on March 17-18, 2017 in Warsaw, Poland.

Read more

Lymphomas from A to Z

IMG 20170312 121401

Nineteen countries from 3 continents were represented during the EHA-SWG Scientific Meeting on Rare Lymphomas on March 10-12, 2017 in Barcelona, Spain.

Read more

Lymphoma, multiple myeloma and marrow failure syndromes better understood during…

Hematologists from Sri Lanka and surrounding countries learned how to best care for patients with lymphoma, multiple myeloma and bone marrow failure syndromes and stem cell transplantation during the joint…

Read more

EuroBloodNet aims for better care for patients with rare blood disorders

eurobloodnet

Patients suffering from rare blood disorders will benefit from networks of excellence across the European Member States. At the 3rd conference on European Reference Networks in Lithuania, EuroBloodNet was officially awarded as one of the recently approved ERNs.

Read more

Impact of new technologies on diagnosis and treatment of anemias highlighted in …

IMG 20170203 124812

Hematologists from 18 countries and 4 continents learned more about the new techniques for diagnosis and treatment of anemias during the EHA-SWG Scientific Meeting on Anemias on February 2-4, 2017…

Read more

EHA in the BioMed Alliance: joining forces for biomedical research

biomedall

EHA is an active member of the Alliance for Biomedical Research in Europe (BioMed Alliance), in which Europe’s leading medical societies have joined forces to represent the interests of over 400,000 researchers and health professionals.

Read more

HARMONY: Better care of patients with hematologic malignancies kicked off!

Logo Harmony Horizontal FullText

“Combining data available from clinical trials as well as real world patients allows us to do more advanced analyses on possible treatment options that could be effective for individual patient…

Read more

EHA’s advocacy for hematology continues

AdobeStock 92093794

EHA is entering the next phase of its Hematology Awareness Campaign this fall. Face-to-face meetings will be conducted with EU institutions and other relevant stakeholders in Brussels, to raise awareness in hematology, increase the visibility of EHA, advocate key EHA positions, contribute to important policy debates and build relationships and alliances.

Read more

Young researchers to benefit from EHA training and mentoring

AdobeStock 135129739

Participation in EHA-CRTH will allow these researchers to fine-tune the skills and knowledge required to successfully design, run and complete clinical trials.

Read more

EHA-funded study in The Lancet Haematology: Economic Burden of Blood Disorders i…

lancet

Two studies funded by EHA and published in the medical journal Lancet Haematology by a team of researchers from Oxford University and King’s College found that the economic burden of blood disorders (malignant and non-malignant) across the European Union, Iceland, Norway and Switzerland amounts to €23 billion per year.

Read more